CervoMed (CRVO) EBT Margin (2011 - 2025)
CervoMed (CRVO) reported EBT Margin of -92718.10% for Q4 2025, down 92407.80 percentage points from -310.30% a year earlier and down 90323.13 percentage points from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) EBT Margin (2011 - 2025) Analysis & Trends
For FY2025, CervoMed posted EBT Margin of -672.86%, down 505.58 percentage points from FY2024.
- By year, EBT Margin came in at -167.28% in FY2024 (-61.00 pp) and -106.28% in FY2023.
- The Q4 2025 figure ranks as the lowest quarterly EBT Margin in data going back to Q3 2011.
- Year over year, EBT Margin has now declined in each of the last six quarters, with an average year-over-year change of -11910.93 percentage points over the last eight quarters.
- The high point for year-over-year EBT Margin in five years was Q2 2024 (a gain of 0.11 percentage points); the low point was Q4 2025 (a drop of 92407.80 percentage points).
- Per Business Quant data, the three quarters before Q4 2025 came in at -2394.96% (Q3 2025), -355.47% (Q2 2025) and -255.22% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | CervoMed | 23.77 Mn | -62.25 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -92,718.10% |
| Sep 30, 2025 | -2,394.96% |
| Jun 30, 2025 | -355.47% |
| Mar 31, 2025 | -255.22% |
| Dec 31, 2024 | -310.30% |
| Sep 30, 2024 | -244.88% |
| Jun 30, 2024 | -70.44% |
| Mar 31, 2024 | -107.12% |
| Dec 31, 2023 | -94.83% |
| Sep 30, 2023 | -172.13% |
| Jun 30, 2023 | -70.54% |
| Mar 31, 2023 | -98.80% |
| Jun 30, 2022 | -7,667.09% |
| Mar 31, 2022 | -16,377.61% |
| Sep 30, 2021 | -24,932.53% |
| Jun 30, 2021 | -6,840.68% |
| Mar 31, 2021 | -11,490.30% |
| Dec 31, 2020 | -16,241.08% |
| Sep 30, 2020 | -17,941.67% |
| Jun 30, 2020 | -14,018.25% |
API Access
CervoMed EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();